Vol. 3, No. 4

April 2004

Jerry Bylander, Editor  jerryby@cableone.net

FEATURE ARTICLES

The Director's Column

First, I hope everyone has read Dr. Bylander's article on hospital shortfalls in the March edition of the Director's Column.  Second, I would like to take a moment and remind everyone that this
local USToo! prostate group was founded by R.B. McGowen, a retired attorney, who resides in Sherman, Texas.  And that brings me to issue of prostate cancer reoccurrence which I would like to discuss in an optimistic way.  Most of you who attend our meetings regularly know that one in three men suffer prostate cancer reoccurrence after they have primarily treated by their doctor. This happens for a variety of reasons.  First, possibly the cancer was not as curable as originally it was thought to be.  Second, the therapy was not carried out in the hands of an artist.  Third is explained by the old proverb that one was just unfortunate.  However the fact remains a man still has PC and must continue to battle the prostate cancer.

This brings us to the topic of androgen deprivation therapy which is also well known as "hormonal therapy".  In short, this therapy is designed to rid the male body of testosterone which is the male androgen that all prostate cells need for growth and proliferation.  When this therapy is given under the direction of a knowledgeable physician it can add years of overall survival benefits to a man with systemic prostate cancer.  This therapy, when first presented to a prostate cancer patient, seems to require an overwhelming amount of information to digest.  To simplify, I will discuss the therapy in what I hope will be an easy way to understand.  First, medical personnel have basically two methods at their disposal to administer this therapy.  One is physical castration (removal of the testes) or chemical castration that is usually achieved with a combination of drug therapies.  Please understand there are two sites that produce testosterone: the testes and the adrenal glands.  Both must be eliminated as a source to give this therapy a fair shake.

Now one must understand any modality for treating prostate cancer has adverse effects.  For hormonal therapy the effects may be some or all of these:

loss of libido
weight gain
depression
bone resorption
anemia
fatigue

However there are medications to correct most if not all of the adverse side effects.  Here are the optimistic thoughts about the above treatment, as of 2003.  The Department of Defense that oversees the Veterans Administration and active military base health care, announced that their data shows that when hormonal therapy is provided properly, that men had an overall 10 year
survival rate on this therapy.  But more than that, back to our founder, Mr. McGowen, he has been on hormonal therapy for some thirteen years and the cancer shows little sign of progressing at this point.  Hoorah!  Also there is another man who resides in Sherman, Texas named Mr.Farley that is an acquaintance of mine who has been on hormonal therapy for over sixteen years and the therapy is still effective.  In conclusion if you are anyone you know is on hormonal therapy or will be going on hormonal therapy, please attend our seminars and learn how this therapy should be administered properly to reduce the risk of flare* and also to insure one will get the maximum benefit from this therapy such as having their testosterone level checked regularly.  These tests will insure that this therapy is being administered properly.  Our local Us-Too! group hopes to remove the fear and misunderstandings of how to live and survive in a productive way with the disease of prostate cancer.  See you at our next meeting,

Henri Plunkett, Director

*  Flare can be discussed at any of our meetings.

See you at the April meeting

    Dr. Jerry Bylander, Managing Director, USToo! Texoma

    Back to Top

    Next Meeting


    "
    A Hands-On Tutorial on How to Find the Latest Prostate Cancer Treatment Information"

    Date: Tuesday Evening, April 20, 2004
    Location:  
    Wilson N. Jones Annex, 501 North Highland Street
    (Directions - the Annex is across the street from the main lobby of Wilson N. Jones main building.  Go down the hill on West Hillcrest and turn right into the driveway (left if going uphill) and then park at the top of the parking lot.  Come into the northeast door and enter the Information Technology classroom straight ahead.)

    6:30 PM - Social & Coffee
    7:00 PM - Program

    Facilitators:  Henry Plunkett and the Wilson N. Jones staff
    Program: You will learn how to access various national and international hospital and health group websites in order to find the latest prostate cancer treatments.  There will be 10 to 12 computers available, all connected to the Internet.  We will also have a handout with a select list of useful prostate cancer sites listed.

    Facilitator Henri has spent many hours at his computer finding new research results and treatments for our group.

    Back to Top

    Last Meeting
    Date & Time: Tuesday, January 20,  2004, 7:00 PM
    Place: Wilson N. Jones, North Campus
    Attendance: approximately 12 attendees


    Old Business

     None

    New Business

     We discussed the internet training we planned for April and possibly June.

    Program:   "Texas Cancer Center Radiation Facilities: a tour and an explanation",      

    Speaker:  Dr. Mary Hebert, Texas Cancer Center - Sherman and Denison

    Program:  Although we had a small turnout, this was one of our most successful meetings.  We had three newly diagnosed men who had many questions about available treatments.  It seemed to be helpful to them to see the radiation facilities and also the seed implant template.  Also other members present were able to discuss their treatments and outcomes.

    The meeting adjourned about 9 PM.

    Henri Plunkett, Program Chair/by the Editor

    Back to Top

    Other Important Events
    Your organization's meetings listed here.  Contact the Editor at jerryby@cableone.net

    Back to Top

    Editor's Notes

     An Important Source for Prostate Cancer Information

    The Department of Defense prostate cancer web site is an extremely good source of the latest PC information.  For example from their website:

    Released 4/4/04
      "Prostate Cancer Early Detection Guidelines (2004)"

    The new guidelines recommend a baseline PSA for all men at age 40 and a PSA cutoff of 2.6.  The age 40 baseline is on page PROSD-1 and elsewhere.  The 2.6 is on page PROSD-3 and elsewhere.  The wording used is very important.  Also note that, if the baseline PSA at age 40 is less than 0.6, the next test should be given at age 45.  If that test is less than 0.6; then regular annual screening starts at age 50.  Note also that complexed PSA is now mentioned as an alternative to total PSA .

     The URL is www.cpdr.org